Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. [electronic resource]
Producer: 20100617Description: 241-8 p. digitalISSN:- 2146-8427
- Adult
- Adult Stem Cells -- immunology
- Antigens, CD34 -- analysis
- Bone Marrow Transplantation -- adverse effects
- Female
- Humans
- Male
- Middle Aged
- Motor Activity
- Nerve Regeneration
- Paraplegia -- etiology
- Pilot Projects
- Quadriplegia -- etiology
- Recovery of Function
- Sensation
- Severity of Illness Index
- Spinal Cord Injuries -- complications
- Spinal Puncture
- Stem Cell Transplantation -- adverse effects
- Time Factors
- Transplantation, Autologous
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.